Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This BBB disruption is defined by the loss of cerebrovascular endothelial cell tight junction integrity. and is governed by perforin expressing CD8 T cell response, consistent with our findings in experimental cerebral malaria24, 31 33.”
In the citing paper
“This pore-forming protein is critical for cell death and viral clearance during infectious diseases, and it has been defined as a key mechanism for BBB disruption in ECM and the PIFS model24, 25.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Eugenin, E. A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T. M., & Berman, J. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3863-05.2006 · Cited by 392
Perforin is a critical physiologic regulator of T-cell activation
Lykens, J. E., Terrell, C. E., Zoller, E. E., Risma, K., & Jordan, M. B. (2011) · Blood · doi:10.1182/blood-2010-12-324533 · Cited by 150
Research works printed but not linked: 45
- Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001;24:719–25. · DOI · Paper page
- Brown H, Hien TT, Day N, Mai NT, Chuong LV, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25:331–40. · DOI · Paper page
- Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, et al. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol. 2012;180:246–55. · DOI
- Marchi N, Johnson AJ, Puvenna V, Johnson HL, Tierney W, et al. Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia. 2011;52:1627–34. · DOI
- Marchi N, Granata T, Ghosh C, Janigro D. Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia. 2012;53:1877–86. · DOI · Paper page
- Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitol. 2006;36:555–68. · DOI · Paper page
- Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9:540–9. · DOI · Paper page
- Pirko I, Suidan GL, Rodriguez M, Johnson AJ. Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation. 2008;5:31. · DOI
- Schneider SW, Ludwig T, Tatenhorst L, Braune S, Oberleithner H, et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol. 2004;107:272–6. · DOI · Paper page
- Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85:1801–13. · DOI · Paper page
- An J, Zhou DS, Zhang JL, Morida H, Wang JL, et al. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett. 2004;95:167–74. · doi:10.1016/j.imlet.2004.07.006
- Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, et al. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol. 2004;172:3297–304. · DOI · Paper page
- Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, et al. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol. 2010;184:1031–40. · DOI · Paper page
- Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One. 2008;3:e3037. · DOI · Paper page
- Johnson HL, Willenbring RC, Jin F, Manhart WA, LaFrance SJ, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS One. 2014;9:e111401. · DOI · Paper page
- Johnson HL, Chen Y, Jin F, Hanson LM, Gamez JD, et al. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol. 2012;189:1937–45. · DOI
- Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood. 2005;105:4700–6. · DOI
- An O, Gursoy A, Gurgey A, Keskin O. Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients. Protein Sci. 2013;22:823–39. · DOI
- Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, Soderhall C, Samuelsson A, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590–7. · DOI · Paper page
- Mhatre S, Madkaikar M, Desai M, Ghosh K. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India. Blood Cells Mol Dis. 2015;54:250–7. · DOI
- Muralitharan S, Wali YA, Dennison D, Lamki ZA, Zachariah M, et al. Novel spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis in ethnic Omani patients. Am J Hematol. 2007;82:1099–102. · DOI
- Voskoboinik I, Thia MC, De Bono A, Browne K, Cretney E, et al. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J Exp Med. 2004;200:811–6. · DOI
- Zhang K, Johnson JA, Biroschak J, Villanueva J, Lee SM, et al. Familial haemophagocytic lymphohistiocytosis in patients who are heterozygous for the A91V perforin variation is often associated with other genetic defects. Int J Immunogenet. 2007;34:231–3. · DOI
- Zur Stadt U, Beutel K, Weber B, Kabisch H, Schneppenheim R, et al. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood. 2004;104:1909. author reply 1910. · DOI · Paper page
- House IG, Thia K, Brennan AJ, Tothill R, Dobrovic A, et al. Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals. Immunol Cell Biol. 2015;93:575–80. · DOI · Paper page
- Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–9. · DOI · Paper page
- Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA. Perforin: structure, function, and role in human immunopathology. Immunol Rev. 2010;235:35–54. · DOI · Paper page
- Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, et al. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2013;2:e24185. · DOI
- Revelo XS, Tsai S, Lei H, Luck H, Ghazarian M, et al. Perforin is a novel immune regulator of obesity related insulin resistance. Diabetes. 2015;64(1):90–103. · DOI · Paper page
- Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, et al. Variations of the perforin gene in patients with type 1 diabetes. Diabetes. 2008;57:1078–83. · DOI
- Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, et al. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol. 2005;15:1022–7. · DOI · Paper page
- Brennan AJ, House IG, Oliaro J, Ramsbottom KM, Hagn M, et al. A method for detecting intracellular perforin in mouse lymphocytes. J Immunol. 2014;193:5744–50. · DOI
- Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, et al. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol. 1998;153:417–28. · DOI · Paper page
- Pavelko KD, Girtman MA, Mitsunaga Y, Mendez-Fernandez YV, Bell MP, et al. Theiler’s murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS One. 2011;6:e20217. · DOI
- Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, et al. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol. 2005;174:6854–62. · DOI · Paper page
- Pirko I, Nolan TK, Holland SK, Johnson AJ. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model. Radiology. 2008;246:790–5. · DOI
- Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, et al. MRI in rodent models of brain disorders. Neurotherapeutics. 2011;8:3–18. · DOI
- Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M. Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage. 2004;21:576–82. · DOI
- Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, et al. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage. 2011;54:802–6. · DOI
- Vadnie CA, Hinton DJ, Choi S, Choi Y, Ruby CL, et al. Activation of neurotensin receptor type 1 attenuates locomotor activity. Neuropharmacology. 2014;85:482–92. · DOI
- Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen LP, et al. Prevalent class I-restricted T-cell response to the Thelier’s virus epitope D-b : VP2(121-130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol. 1999;73:3702–8. · DOI · Paper page
- Brennan AJ, Chia J, Trapani JA, Voskoboinik I. Perforin deficiency and susceptibility to cancer. Cell Death Differ. 2010;17:607–15. · DOI
- Urrea Moreno R, Gil J, Rodriguez-Sainz C, Cela E, LaFay V, et al. Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function. Blood. 2009;113:338–46. · DOI
- Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121:5184–91. · DOI · Paper page
- Terrell CE, Jordan MB. Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice. Blood. 2013;122:2618–21. · DOI
Cited by
Lee, L. L., Aung, H. H., Wilson, D. W., Anderson, S. E., Rutledge, J. C., & Rutkowsky, J. M. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00120.2016 · Cited by 65
Johnson, A., Seady, M., Maynes, M., Thelwell, J., Jin, F., Hansen, M., Jensen, H., Witter, R., Owens, C., Hassani, A., et al. (2026) · doi:10.21203/rs.3.rs-10061124/v1
Self-citation
Metadata
- Authors
- Willenbring, R. C., Jin, F., Hinton, D. J., Hansen, M., Choi, D.-S., Pavelko, K. D., & Johnson, A. J.
- Venue
- Journal of Neuroinflammation
- Published
- 2016-08-31
- Volume
- 13
- Issue
- 1
- ISSN
- 1742-2094
- Cited by
- 26
- References
- 3
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- National Institutes of Health (RO1 NS060881)
- National Institute of Neurological Disorders and Stroke (R56 NS94150)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption. https://app.cochat.ai/papers/10.1186/s12974-016-0673-9
- The paper
- Willenbring, R. C., Jin, F., Hinton, D. J., Hansen, M., Choi, D.-S., Pavelko, K. D., & Johnson, A. J. (2016). Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-016-0673-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.